March 23, 2020
Joji Nakayama, president of the Japan Pharmaceutical Manufacturers Association (JPMA), said on March 19 that JPMA member companies are making voluntary efforts to increase their stockpiles of drugs to deal with the COVID-19 pandemic in order to ensure their stable...read more